Clinical trial
Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
NCT00004038 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004038 |
|---|---|
| Title | Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer |
| Official title | Pilot Study of p53 Intralesional Gene Therapy With Chemotherapy in Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | Ad5CMV-p53 gene, chemotherapy |
| Enrollment | 20 |
| Start date | Jan 1, 1999 |
| Primary completion | May 1, 2001 |
| First posted | May 20, 2004 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: